Unibest

Pharmaceutical intermediates

Lurasidone (Intermediates ONLY) Intermediates

3 pharmaceutical intermediates for Lurasidone (Intermediates ONLY). Indication: Major depressive disorder; Schizophrenia; Mania.

Submit a ProjectAll intermediates

About Lurasidone (Intermediates ONLY)

Originator
Dainippon Sumitomo Pharma Co., Ltd
Indication
Major depressive disorder; Schizophrenia; Mania
Approved Date
10/28/2010
DS/DP
05/26/2026

Available intermediates

3 intermediates currently listed for Lurasidone (Intermediates ONLY). Request specifications, documentation or a quotation for any item below.

Lurasidone (Intermediates ONLY) intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione14805-29-9//
(1R,2R)-1,2-Cyclohexanedimethanol65376-05-8//
(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane186204-35-3//

Other programs under L

(LCZ696)LanifibranorLapatinibLarotrectinibLasmiditanLazertinib MesylateLemborexantLenacapavir sodium

Building toward Lurasidone (Intermediates ONLY)?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →